Medibay Pharma Private Limited
About Medibay Pharma Private Limited
Data last updated:
Medibay Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51397UP2021PTC141183. Its GSTIN is 09AAOCM2664F1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Ayesha Makhija and Dheeraj Makhija.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. A – 78 Rajajipuram Avas Vikas Talkatora Road, Lucknow, Uttar Pradesh, India – 226017.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.82 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹16.95 Lakh (net margin 4.4%) and EBITDA of ₹24.2 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
As per MCA filings, the company has open charges of ₹20.23 Lakh on record.
Company details
Contact details
Medibay Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. A – 78 Rajajipuram Avas Vikas Talkatora Road, Lucknow, Uttar Pradesh, India – 226017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medibay Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medibay Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medibay Pharma Private Limited, buy the company report.
Financials of Medibay Pharma Private Limited
FY 2025 filings availableMedibay Pharma Private Limited reported revenue of ₹3.82 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 17% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medibay Pharma Private Limited, buy the company report.
Board of directors of Medibay Pharma Private Limited
Medibay Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayesha Makhija | Director | 03 Feb 2021 | 5 Years 9 Months | Current |
| Dheeraj Makhija | Director | 03 Feb 2021 | 5 Years 9 Months | Current |
Peer comparison
Medibay Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jhoro Footwear India Private Limited | ₹3.83 Cr (FY 2018) | -25.0% | Hyderabad, Telangana, India | |||
| Jyoti Granimarmo Private Limited | ₹3.83 Cr (FY 2024) | -12.0% | Jaipur, Rajasthan, India | |||
| Shri Ram Limechem Private Limited | ₹3.83 Cr (FY 2024) | 8.0% | Jodhpur, Rajasthan, India | |||
| Steelx Tool Steel Private Limited | ₹3.82 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Kashi Prayag Exports Private Limited | ₹3.82 Cr (FY 2016) | Delhi, India | ||||
| Medibay Pharma Private Limitedthis company | ₹3.82 Cr (FY 2025) | ₹16.95 Lakh | 4.4% | 17.0% | Lucknow, Uttar Pradesh, India | |
| Nextzen Workplace Solutions Private Limited | ₹3.82 Cr (FY 2024) | 0.0% | Bhopal, Madhya Pradesh, India | |||
| Friend's Industrial Suppliers Private Limited | ₹3.82 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Jayalaxmi Minerals & Resources Private Limited | ₹3.82 Cr (FY 2021) | -89.0% | Hyderabad, Telangana, India | |||
| Southern Super Market Private Limited | ₹3.82 Cr (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| NCM India Limited. | ₹3.82 Cr (FY 2024) | -93.0% | New Delhi, Delhi, India |
To see the full peer comparison of Medibay Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2025 | 101145668 | Hdfc Bank Limited | ₹20.23 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medibay Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medibay Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medibay Pharma Private Limited has 1 active EPFO establishment as of Mar 27, 2024.
GST
Medibay Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAOCM2664F1Z6 | Uttar Pradesh | Active | 19 Mar 2021 |
To see the full GST registrations and return filing status of Medibay Pharma Private Limited, buy the company report.
Recent activity
Medibay Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ayesha Makhija was appointed as Director on 03 Feb 2021.
Frequently asked questions
Medibay Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2021 (5+ years old) and is registered under CIN U51397UP2021PTC141183.
Medibay Pharma has 2 current directors:
- Ayesha Makhija - Director
- Dheeraj Makhija - Director
The latest financial statements of Medibay Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Medibay Pharma is 09AAOCM2664F1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medibay Pharma is U51397UP2021PTC141183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medibay Pharma was incorporated on 03 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Medibay Pharma by revenue are Jhoro Footwear India Private Limited, Jyoti Granimarmo Private Limited, Shri Ram Limechem Private Limited, Steelx Tool Steel Private Limited, Kashi Prayag Exports Private Limited and 5 more, all in the same principal business activity (retail trading).
Ayesha Makhija was appointed as Director on 03 Feb 2021. Dheeraj Makhija was appointed as Director on 03 Feb 2021.
The registered office of Medibay Pharma is at House No. A – 78 Rajajipuram Avas Vikas Talkatora Road, Lucknow, Uttar Pradesh, India – 226017.
Medibay Pharma operates in the pharma industry, in the drug formulation and development segment.
Medibay Pharma has open charges of ₹20.23 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
